Track record · closed signal

CareTrust REIT, Inc. (CTRE) — closed signal from November 14, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on February 12, 2026.

Predicted vs. what happened

CTRE price · publication thesis → realized outcomesplit-adjusted
$35.70 Published $39.62 Target $40.14 Window close $40.41 Peak
$34.37 – $35.35Entry zone — fair-value band
$35.70Published — price the day we called it
$39.62Target — the price the thesis aimed for
$40.41Peak — highest point inside the window, not a realized return
$40.14Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 90 days.

Peak price
$40.41
peak on February 12, 2026 — not a realized return
Peak gain
+13.2%
peak, from the publication price
Window close
$40.14
end-of-window price, context only
Days to target
90
Window
November 14, 2025 – February 12, 2026

The thesis — published November 14, 2025

Predicted growth
+12%
over the measurement window
Target price
$39.62
the price the thesis aimed for
Entry zone
$34.37 – $35.35
the fair-value band we waited for
Price at publication
$35.70
published November 14, 2025
Confidence
85%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

CareTrust looks set for a steady three-month hold. Cash profits per share rose 18% in the latest quarter, and new property buys are adding to growth. Even after a 35.7% rise this year, several analyses say the shares still look inexpensive. Recent average price trends and signs of stronger buying suggest pullbacks can be chances to start or add, with dividends plus a small bump in valuation driving returns.

Primary drivers

  • Latest quarter showed cash profits per share up 18%, strengthening cash flow
  • Recent average price is trending higher, and buying interest looks healthier
  • Recent property purchases add income and make future growth easier
  • Recent cash-value estimate suggests the stock could still climb

How it played out

CTRE: target reached in 90 days

Lyra published CTRE on 2025-11-14 at 35.7 with a short-term thesis for 12% growth. The thesis pointed to cash profits per share up 18% in the latest quarter, higher recent average price trends, healthier buying interest, recent property purchases, and a cash-value estimate that suggested the stock could still climb.

Inside the window from 2025-11-14 to 2026-02-12, CTRE reached 40.41 on 2026-02-12 against a 39.62 target. It got there in 90 days. The peak gain was 13.2%. It ended at 40.14. The published thesis played out.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.